United States · Series A startup
4 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$25Mraised across 4 rounds since 2010, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
New Enterprise Associates
Windham Capital PartnersFrom a historical funding record
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Enterprise AssociatesWindham Capital PartnersNanjing Kaiyuan Growth Capital InvestmentsMissing a round, or an investor who was in one? Tell us.
Personal Genome Diagnostics (PGD)'s investors include New Enterprise Associates, Windham Capital Partners and Nanjing Kaiyuan Growth Capital Investments.
Personal Genome Diagnostics (PGD) has raised $25M across 4 rounds since 2010.
Personal Genome Diagnostics (PGD)'s most recent round was a Series A of $21M in Oct 2015.
Its most recent round, $21M in Oct 2015, is also its largest on record.
Personal Genome Diagnostics (PGD)'s first round on record, in Oct 2015, was backed by New Enterprise Associates, Windham Capital Partners and Nanjing Kaiyuan Growth Capital Investments.
Personal Genome Diagnostics (PGD)'s latest named round is a Series A, in Oct 2015.
Personal Genome Diagnostics (PGD) is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·